HomeSHRX • CVE
add
Sharp Therapeutics Corp
Previous close
$0.50
Year range
$0.50 - $2.28
Market cap
14.99M CAD
Avg Volume
60.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.32M | 117.21% |
Net income | -3.25M | -164.59% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.32M | -132.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.02M | 435.07% |
Total assets | 3.16M | — |
Total liabilities | 3.82M | — |
Total equity | -662.71K | — |
Shares outstanding | 29.94M | — |
Price to book | -25.00 | — |
Return on assets | -85.75% | — |
Return on capital | -145.48% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.25M | -164.59% |
Cash from operations | -1.39M | -132.02% |
Cash from investing | — | — |
Cash from financing | -50.00K | -111.11% |
Net change in cash | -1.47M | -710.60% |
Free cash flow | 967.34K | — |
About
Founded
2021
Headquarters
Website
